INFIRST+ HEALTHCARE
Infirst Healthcare Inc.
Application Filed: 2020-12-02
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90355194 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Dean G. Stathakis |
| Attorney Docket Number | UEINF2-0069 |
Timeline
| 2014-08-20 | Date of First Use |
| 2020-12-02 | Application Filed |
| 2020-12-05 | Location: NEW APPLICATION PROCESSING |
| 2020-12-05 | Status: Live/Pending |
| 2020-12-05 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Infirst Healthcare Inc. |
| Address | 8 Church Lane Westport DE 06880 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals and veterinary preparations and substances; pharmaceuticals and veterinary medications for the treatment and prevention of cancer, cardiovascular, endocrine or hormonal, gastrointestinal, inflammatory, musculoskeletal, microbial, neurodegenerative, neurological, urological conditions, diseases and disorders; antipyretic, analgesics, and anti-inflammatory medications; pain medications; headache and migraine medications; cough, cold and fever medications; heartburn, upset stomach, acid reflex, and acid indigestion medications; diarrhea medications; anti-microbial, anti-viral, and anti-bacterial medications; burn relief medications; allergy and antihistamine medications; acne medications |
| GS0051 | Pharmaceutical preparations and substances and veterinary pharmaceutical preparations and substances for the treatment and prevention of cancer, cardiovascular, endocrine or hormonal, gastrointestinal, inflammatory, musculoskeletal, microbial, neurodegenerative, neurological, urological conditions, diseases and disorders; antipyretic, analgesics, and anti-inflammatory medications; pain relief medications; headache treatment and migraine treatment preparations; cough, cold and fever relief medications, namely, allergy tablets, chewable tablets, cough pastilles for medical use, throat lozenges, and medicinal syrups for the treatment of cough, cold and fever, heartburn, upset stomach, acid reflex; acid indigestion relief medications; diarrhea relief medications; anti-microbial, anti-viral, and anti-bacterial medication[s] and preparations for treating microbial, viral, and bacterial infections, burn relief medications; allergy relief medications; antihistamines; acne medications |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-12-05 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-02-08 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-05-18 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-06-04 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-06-04 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-06-04 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-12-03 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-12-03 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-12-04 | 9 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2022-01-07 | 10 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2022-01-07 | 11 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-01-07 | 12 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-06-06 | 13 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-06-06 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-06-07 | 15 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2022-07-06 | 16 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2022-07-06 | 17 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-07-06 | 18 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-10-19 | 19 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-10-19 | 20 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-10-19 | 21 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2022-11-08 | 22 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2022-11-08 | 23 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-11-08 | 24 GNEN O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2022-11-08 | 25 ALIE A:Allowance for Publication |
| EXAMINER'S AMENDMENT ENTERED | 2022-11-08 | 26 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-12-02 | 27 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-12-21 | 28 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2023-01-10 | 29 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-01-10 | 30 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2023-03-28 | 31 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-03-28 | 32 NRCC E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2024-04-29 | 33 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2024-04-29 | 34 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-04-29 | 35 TCCA I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 